2017
DOI: 10.1016/j.ijpharm.2017.03.040
|View full text |Cite
|
Sign up to set email alerts
|

Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
31
0
4

Year Published

2017
2017
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 65 publications
(36 citation statements)
references
References 56 publications
1
31
0
4
Order By: Relevance
“…QE could also inhibit migration of medulloblastoma cells, 52 teratocarcinoma cells, 53 and breast cancer cells. 54 Therefore, we evaluated the role of QE on invasion and migration in LM3 cells. Using morphological observations, western blotting, qRT-PCR, and immunofluorescence analyses, QE was shown to reverse the phenomenon of invasion and migration.…”
Section: Discussionmentioning
confidence: 99%
“…QE could also inhibit migration of medulloblastoma cells, 52 teratocarcinoma cells, 53 and breast cancer cells. 54 Therefore, we evaluated the role of QE on invasion and migration in LM3 cells. Using morphological observations, western blotting, qRT-PCR, and immunofluorescence analyses, QE was shown to reverse the phenomenon of invasion and migration.…”
Section: Discussionmentioning
confidence: 99%
“…Studies have reported that LPS treatment enhances the migration of cells in RAW264.7 macrophages [56]. MMP-2 is the most important metalloproteinase, is involved in tumor migration, invasion, and metastasis, and is also known to regulate inflammation [57]. We first measured MMP-2 activity by Western blotting and found that it was timedependently (0 to 60 min) increased in LPS-induced RAW264.7 cells.…”
mentioning
confidence: 96%
“…However, a large number of studies, using different techniques, have been published with a NP and CTH-based approach for both PCa and BC, of which only a tiny fraction are listed here [105,253,315,353,422,423,424,425,426,427,428,429,430,431]. For example, Belz et al recently designed ultra-small silica NPs containing the radiosensitizing drug docetaxel for combined chemoradiation therapy, with potential benefit for patients with PCa [425].…”
Section: Multimodal Therapy Options For Prostate and Breast Cancermentioning
confidence: 99%
“…For example, Belz et al recently designed ultra-small silica NPs containing the radiosensitizing drug docetaxel for combined chemoradiation therapy, with potential benefit for patients with PCa [425]. For BC, Li et al found synergistic inhibition of both migration and invasion of 4T1 BC cells by doubly loaded NPs (docetaxel + the Akt inhibitor quercetin), via the Akt/matrix metallopeptidase 9 (MMP-9) pathway [431]. …”
Section: Multimodal Therapy Options For Prostate and Breast Cancermentioning
confidence: 99%